The ordinary general meeting (OGM) of Cleopatra Hospital Company approved cash dividends to employees amounting to EGP 84.089 million for 2025

Cleopatra Hospital Company’s (CLHO) consolidated net profits attributable to the parent company rose by 13.9% year on year (YoY) in 2025 to EGP 823.881 million, compared to EGP 723.346 million in 2024.

Cleopatra Hospital Company posted 39.39% year-on-year (YoY) higher consolidated net profits after income tax at EGP 838.919 million in the first nine months of 2025

Cleopatra Hospital Company has seen a trading transaction valued at EGP 44.815 million within the framework of the employee stock ownership plan (ESOP).

Cleopatra Hospital Company is expected to deliver revenue growth of more than 30% year-on-year (YoY) in the third quarter (Q3) of 2025 and over 35% for the nine months of 2025, according to a bourse statement.

Cleopatra Hospital Company’s consolidated net profits attributable to the parent company rose 38.68% year on year (YoY) in the first half (H1) of 2025 to EGP 450.986 million, versus EGP 325.193 million, the firm stated.

The Financial Regulatory Authority (FRA) of Cleopatra Hospital Company greenlighted a capital reduction to EGP 721.892 million from EGP 722.717 million

Cleopatra Hospital Company’s general assembly approved cash dividends amounting to EGP 79.840 million for 2024.

Cleopatra Hospital Group has executed an agreement to extend Cleopatra October Hospital (Haven) by adding around 200 beds through a build-to-suit lease.

Cleopatra Hospital Company logged consolidated net profits attributable to the parent company worth EGP 532.39 million in the first nine months of 2024, compared to EGP 310.95 million a year earlier.

Cleopatra Hospital Company has seen a trading transaction valued at EGP 11.647 million within the framework of the employee stock ownership plan (ESOP).

Cleopatra Hospital Company has seen a trading transaction valued at EGP 11.647 million within the framework of the employee stock ownership plan (ESOP).

Cleopatra Hospital Company’s consolidated net profits attributable to the parent company rose 70% year on year (YoY) in the first half (H1) of 2024 to EGP 325.193 million, versus EGP 191.238 million.

Cleopatra Hospital Company’s consolidated net profits attributable to the parent company went up 92.6% year on year (YoY) in the first quarter (Q1) of 2024, recording EGP 182.231 million, versus EGP 94.593 million.

Cleopatra Hospitals Group (CHG), Egypt's healthcare services provider, has forged a strategic alliance with Fawaz Al Hokair's healthcare arm Mumtada Medical Care Company to inaugurate a cutting-edge 200-bed rehabilitation and long-term care center in Riyadh.

Cleopatra Hospital Company’s consolidated net profits attributable to the parent company rose by 28.4% year on year (YoY) in 2023 to EGP 418.181 million, compared to EGP 325.763 million.

Cleopatra Hospital Company’s consolidated net profits attributable to the parent company increased by 25.9% year-on-year (YoY) during the first nine months of 2023 to EGP 310.959 million from EGP 246.932 million.

Cleopatra Hospital Company’s consolidated net profits attributable to the parent company inched down 1.4% year on year (YoY) in the first quarter (Q1) of 2023.

Cleopatra Hospital Company’s consolidated net profits after tax and non-controlling interest dropped 15.9% year on year to EGP 325.76 million in 2022, compared to EGP 387.25 million.